Log In

Forgot Password?
Create New Account

Loading... please wait

Abstract Details

Guillain-Barré Syndrome Trend of Hospital Length of Stay, Complication Rate and Mortality Depending from Method of the Treatment: IVIg vs. PLEX
Neuromuscular and Clinical Neurophysiology (EMG)
P5 - (-)
137
Authors/Disclosures
Alexander G. Gevorgyan, MD (Alexander G Gevorgyan, MD Inc)
PRESENTER
No disclosure on file
Nerses Sanossian, MD, FAAN (Department of Neurology, USC) Dr. Sanossian has received personal compensation for serving as an employee of Univeristy of Southern California. Dr. Sanossian has received personal compensation in the range of $10,000-$49,999 for serving on a Scientific Advisory or Data Safety Monitoring board for Medtronic. Dr. Sanossian has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Genentech. Dr. Sanossian has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Portola. The institution of Dr. Sanossian has received research support from Diffusion Pharma.
Said R. Beydoun, MD, FAAN (University of Southern California Healthcare Consultation Center 2) Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alnylam. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Takeda. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Alexion. Dr. Beydoun has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Mitsubishi Tanabe. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Janssen. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving as a Consultant for CSL. Dr. Beydoun has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Catalyst. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving as a Consultant for Argenx. Dr. Beydoun has received personal compensation in the range of $500-$4,999 for serving as a Consultant for UCB. Dr. Beydoun has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Octapharma. Dr. Beydoun has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Amylyx. Dr. Beydoun has received personal compensation in the range of $500-$4,999 for serving as a Consultant for Biogen. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alnylam. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Alexion. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for CSL. Dr. Beydoun has received personal compensation in the range of $500-$4,999 for serving on a Speakers Bureau for Grifols. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Takeda. Dr. Beydoun has received personal compensation in the range of $5,000-$9,999 for serving on a Speakers Bureau for Amylyx. Dr. Beydoun has received personal compensation in the range of $10,000-$49,999 for serving on a Speakers Bureau for Argenx. The institution of Dr. Beydoun has received research support from UCB. The institution of Dr. Beydoun has received research support from Sean Healy & AMG Center for ALS. The institution of Dr. Beydoun has received research support from Alexion. The institution of Dr. Beydoun has received research support from Argenx. The institution of Dr. Beydoun has received research support from Sanofi. The institution of Dr. Beydoun has received research support from Amylyx. The institution of Dr. Beydoun has received research support from Janssen. The institution of Dr. Beydoun has received research support from Genentech. The institution of Dr. Beydoun has received research support from Regeneron.